Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evening insulin strategy.

M C Riddle1

  • 1Division of Endocrinology, Oregon Health Sciences University, Portland 97201-3098.

Diabetes Care
|June 1, 1990
PubMed
Summary
This summary is machine-generated.

Evening insulin regimens offer a potential alternative for managing non-insulin-dependent diabetes mellitus (NIDDM). This approach targets fasting hyperglycemia and the dawn phenomenon, with studies indicating safety and effectiveness for diabetes management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reply to the Letter to the Editor: Response to Concerns Raised on MRI Surveillance and Clinical Implications of ARIA in Disease Modifying Treatment.

The journal of prevention of Alzheimer's disease·2024
Same author

Initial Experiences with Amyloid-Related Imaging Abnormalities in Patients Receiving Aducanumab Following Accelerated Approval.

The journal of prevention of Alzheimer's disease·2023
Same author

Assessment of hypoglycaemia during basal insulin therapy: Temporal distribution and risk of events using a predefined or an expanded definition of nocturnal events.

Diabetes & metabolism·2017
Same author

Glycaemic control and hypoglycaemia with insulin glargine 300U/mL versus insulin glargine 100U/mL in insulin-naïve people with type 2 diabetes: 12-month results from the EDITION 3 trial.

Diabetes & metabolism·2017
Same author

Glycaemic control and hypoglycaemia with insulin glargine 300 U/mL compared with glargine 100 U/mL in Japanese adults with type 2 diabetes using basal insulin plus oral anti-hyperglycaemic drugs (EDITION JP 2 randomised 12-month trial including 6-month extension).

Diabetes & metabolism·2017
Same author

New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 2).

Diabetes, obesity & metabolism·2015
Same journal

A Secular Increase in the Incidence of Islet Autoimmunity Among Colorado Children With Moderate-Risk HLA Genotypes.

Diabetes care·2026
Same journal

Clinical and Biochemical Recovery From Immune Checkpoint Inhibitor-Induced Diabetes With Seroconversion of GAD Antibodies.

Diabetes care·2026
Same journal

State Insulin Out-of-Pocket Cap Policies and Estimated Eligible Populations in the United States, 2019-2026.

Diabetes care·2026
Same journal

Genetic Determinants of Macronutrient Intake Are Associated With Specific Food Intake in Youth: A Cohort Study Across Childhood and Adolescence.

Diabetes care·2026
Same journal

A Novel Electronic Medical Record Search Method to Identify Patients With Ketosis-Prone Diabetes: Implications for Discovery of Atypical Diabetes.

Diabetes care·2026
Same journal

Real-Time Continuous Glucose Monitoring Among People With Type 2 Diabetes and End-Stage Kidney Failure Undergoing Maintenance Hemodialysis: A Randomized Clinical Trial.

Diabetes care·2026
See all related articles

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Pharmacology

Background:

  • Non-insulin-dependent diabetes mellitus (NIDDM) management often involves conventional insulin therapy.
  • Physiological insights suggest a rationale for alternative insulin delivery strategies.
  • Fasting hyperglycemia and the dawn phenomenon are key challenges in NIDDM.

Purpose of the Study:

  • To evaluate evening regimens of intermediate-acting insulin as an alternative to conventional therapy for NIDDM.
  • To explore the physiological basis for overnight insulin delivery in NIDDM.
  • To assess the safety and efficacy of evening insulin administration.

Main Methods:

  • Review of clinical studies on evening insulin regimens for NIDDM.
  • Analysis of physiological data related to nocturnal free fatty acids and hepatic insulin sensitivity.

Related Experiment Videos

  • Comparison of evening insulin strategies with conventional insulin therapy.

    • Main Results:

    • Evening insulin regimens demonstrate potential for managing fasting hyperglycemia in NIDDM.
    • Nocturnal free fatty acid concentrations, linked to hepatic insensitivity, can be suppressed by evening insulin.
    • Clinical studies suggest evening insulin regimens are safe and effective.

    Conclusions:

    • Evening insulin regimens represent a promising alternative for NIDDM treatment.
    • Further research is needed to establish the definitive role of evening insulin in clinical practice.
    • This approach may also inform the optimal use of conventional diabetes management strategies.